(Q39127681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

Alberto Alvarez-Barrientos

4 March 2020

author

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Xosé R. Bustelo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

José C García-Borrón

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Pedro Fernández-Salguero

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

María Contador-Troca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Eva Barrasa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Eva M Rico-Leo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Inmaculada Catalina-Fernández

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Mauricio Menacho-Márquez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Aurea Gómez-Durán

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Javier Sáenz-Santamaría

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

10 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

2683-2693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23843039%20AND%20SRC:MED&resulttype=core&format=json

The dioxin (aryl hydrocarbon) receptor as a model for adaptive responses of bHLH/PAS transcription factors

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The aryl hydrocarbon receptor in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The dioxin receptor regulates the constitutive expression of the vav3 proto-oncogene and modulates cell shape and adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-A depletion in the endothelium and transforming growth factor-beta overexpression in the stroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGFbeta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The natural course of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

An evidence-based staging system for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Quantitative detection of melanoma-associated antigens by multimarker real-time RT-PCR for molecular staging: results of a 5 years study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Intra-lymph node prime-boost vaccination against Melan A and tyrosinase for the treatment of metastatic melanoma: results of a phase 1 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Dioxin receptor expression inhibits basal and transforming growth factor β-induced epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Hematopoietic stem cell characterization and isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The dioxin receptor controls β1 integrin activation in fibroblasts through a Cbp-Csk-Src pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Integrins: versatile receptors controlling melanocyte adhesion, migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Mammary stem cells and breast cancer--role of Notch signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Caveolin-1-enhanced motility and focal adhesion turnover require tyrosine-14 but not accumulation to the rear in metastatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

The kynurenine pathway in brain tumor pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248

Characterization of in vitro metabolites of the aryl hydrocarbon receptor ligand 6-formylindolo[3,2-b]carbazole by liquid chromatography-mass spectrometry and NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT248